Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Massimo Galli and Giuliano Rizzardini.
Massimo Galli
Connection Strength
2.260
Giuliano Rizzardini
  1. Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine. Clin Infect Dis. 2021 09 15; 73(6):e1402-e1403.
    View in: PubMed
    Score: 0.242
  2. Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. J Med Virol. 2021 03; 93(3):1421-1427.
    View in: PubMed
    Score: 0.226
  3. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020 07 28; 71(15):889-890.
    View in: PubMed
    Score: 0.224
  4. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacol Res. 2020 08; 158:104931.
    View in: PubMed
    Score: 0.221
  5. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Pharmacol Res. 2020 08; 158:104899.
    View in: PubMed
    Score: 0.220
  6. Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy. J Med Virol. 2020 Sep; 92(9):1637-1640.
    View in: PubMed
    Score: 0.219
  7. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol. 2020 Mar-Apr; 38(2):337-342.
    View in: PubMed
    Score: 0.218
  8. Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience. Eur J Gastroenterol Hepatol. 2018 10; 30(10):1208-1215.
    View in: PubMed
    Score: 0.197
  9. How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group. Front Immunol. 2021; 12:656362.
    View in: PubMed
    Score: 0.059
  10. Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population. Dig Liver Dis. 2021 03; 53(3):263-270.
    View in: PubMed
    Score: 0.058
  11. Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate? Pharmacol Res. 2021 02; 164:105403.
    View in: PubMed
    Score: 0.058
  12. Chest X-ray findings in a large cohort of 1117 patients with SARS-CoV-2 infection: a multicenter study during COVID-19 outbreak in Italy. Intern Emerg Med. 2021 08; 16(5):1173-1181.
    View in: PubMed
    Score: 0.057
  13. Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine. 2020 Oct; 27:100550.
    View in: PubMed
    Score: 0.056
  14. Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med. 2020 06; 76:36-42.
    View in: PubMed
    Score: 0.055
  15. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion. Autoimmun Rev. 2020 07; 19(7):102574.
    View in: PubMed
    Score: 0.055
  16. Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment. New Microbiol. 2018 Apr; 41(2):112-117.
    View in: PubMed
    Score: 0.048
  17. Effect of Cobicistat on Tenofovir Disoproxil Fumarate (TDF): What Is True for TAF May Also Be True for TDF. J Acquir Immune Defic Syndr. 2018 01 01; 77(1):86-92.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.